StockNews.com initiated coverage on shares of NeuroMetrix (NASDAQ:NURO – Free Report) in a research report released on Sunday. The firm issued a sell rating on the medical device company’s stock. NeuroMetrix Stock Performance Shares of NASDAQ NURO opened at $4.10 on Friday. The firm has a market capitalization of $8.16 million, a P/E ratio of […]